Discover Top 10 Companies in Activated Polyethylene Glycol Market: Global Share, Market Size, Revenue Report (2024–2035)
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Introduction
Activated Polyethylene Glycol (PEG) is a chemically modified version of the polymer polyethene glycol that has reactive functional groups at one or both ends of its chain. The activated ends of the PEG molecule allow it to form permanent chemical bonds with various substances, including proteins and peptides, lipids and nanoparticles. The process of PEGylation serves as an essential technology that various industries use. The need for PEGylated therapeutics grows because of two factors, including increased funding for drug delivery systems and the rising rate of chronic disease.
Glenmark Therapeutics Inc., USA, announced its launch of Polyethene Glycol 3350 Powder for Solution 17 grams per capful as an over-the-counter product, which contains the same active component as MiraLAX 2 Powder for Solution 17 grams of Bayer HealthCare LLC. NOF has a long reputation for producing high-quality Activated PEGs, -the SUNBRIGHT Series and high-quality single-molecule PEGs -the PUREBRIGHT Series that possess the most suitable properties for the preparation of physiologically active drugs and biologics.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the activated polyethylene glycol market.
Activated Polyethylene Glycol Market Size & Statistics
- The Market Size for Global Activated Polyethylene Glycol was Estimated to be worth USD 25.43 Billion in 2024.
- The Market is Going to Expand at a CAGR of 12.81% between 2025 and 2035.
- The Global Activated Polyethylene Glycol Market Size is anticipated to reach USD 95.72 Billion by 2035.
- North America is expected to generate the highest demand during the forecast period in the global Activated Polyethylene Glycol market.
- Asia Pacific is expected to grow the fastest during the forecast period in the Global Activated Polyethylene Glycol Market.
Regional Growth and Demand
North America is expected to grow the largest during the forecast period in the global activated polyethylene glycol market. North America is expected to grow the largest due to the high adoption of advanced healthcare technologies and the presence of major pharmaceutical companies. The region's well-established healthcare infrastructure and the increasing prevalence of chronic diseases are driving the demand for PEGylated drugs and medical devices. The continuous investment in research and development and the growing number of clinical trials further bolster the market growth in North America.
Asia Pacific is expected to generate the fastest demand during the forecast period in the global activated polyethylene glycol market. Asia Pacific is expected to grow fastest due to the rapidly expanding pharmaceutical and biotechnology sectors in countries like China and India are significant drivers for market growth. The presence of a large patient pool, increasing healthcare expenditure, and favorable government policies are key factors driving the demand for Activated PEG in this region. The growing focus on improving healthcare infrastructure and the increasing investment in research and development further underscore the market potential in the Asia Pacific region.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the activated polyethylene glycol market.
Top 10 Trends in the Activated Polyethylene Glycol Market
- Rise of PEGylation in Biologics
- High Growth in Multi-Arm PEGs
- Expansion in Targeted Drug Delivery
- Shift Toward Bio-based PEG
- Increased Adoption in Medical Device Coatings
- Emergence of Smart PEGylation
- Regional Dominance of Asia-Pacific
- Strategic R&D Collaborations
- Strict Regulatory Standards
- Application Diversification
1. Rise of PEGylation in Biologics
increasing the hydrodynamic size of molecules, PEGylation reduces renal clearance, allowing for less frequent dosing and better patient compliance. It significantly improves the water solubility and stability of biologics while reducing immunogenicity. As of 2023, there were 38 FDA-approved PEGylated therapeutics, with hematology and oncology dominating the field
2. High Growth in Multi-Arm PEGs
Multi-arm PEGs possess multiple functional groups on a single core, offering greater flexibility and functionality compared to traditional linear structures. Their ability to facilitate dense crosslinking makes them ideal for structural scaffolding in 3D bioprinting and sustained drug-release matrices.
3. Expansion in Targeted Drug Delivery
Activated PEG is a critical component in smart drug delivery systems, particularly those using nanotechnology to localize treatment. PEG chains create a hydration layer that "masks" nanoparticles and lipid carriers from the immune system, preventing rapid clearance by the reticuloendothelial system. PEG-based platforms are increasingly used to target cancerous tissues directly, minimizing damage to healthy cells and reducing side effects.
4. Shift Toward Bio-based PEG
Regulatory pressure and corporate sustainability goals are driving a transition from petroleum-based to renewable PEG sources. Manufacturers are increasingly using ethylene derived from sugarcane or other biomass to produce "green" PEG variants. In 2024, global initiatives for bio-based PEG development received over $150 million in green investment funding
5. Increased Adoption in Medical Device Coatings
The use of activated PEG is expanding beyond injectables into specialized coatings for medical equipment. PEG coatings on catheters, stents, and implants reduce protein adsorption and bacterial adhesion, lowering the risk of infection and thrombosis. In industrial and medical equipment sectors, PEG-based coatings improve wear resistance and anti-corrosion properties by up to 40%.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the global activated polyethylene glycol market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 10 Companies Leading the Activated Polyethylene Glycol Market
- NOF Corporation
- JenKem Technology
- Merck KGaA
- Nektar Therapeutics
- SINOPEG
- Thermo Fisher Scientific
- Dr. Reddy’s Laboratories
- Laysan Bio
- Creative PEGWorks
- SunBio
- Other
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the activated polyethylene glycol market.
1. NOF Corporation
Headquarters: Tokyo, Japan
NOF Corporation is a Japanese chemical manufacturing company headquartered in Tokyo, Japan. Founded in 1937 as Nippon Oil & Fats Co., Ltd., the company produces a wide range of specialty chemicals and materials used in industries such as healthcare, food, electronics, and aerospace. Its main business segments include functional chemicals, pharmaceuticals and health products, and explosives and propulsion systems. The company manufactures products like fatty acids, surfactants, polymers, electronic materials, and drug-delivery component.
2. JenKem Technology
Headquarters: Beijing, China
JenKem Technology is a specialty chemical and biotechnology company focused on the development and manufacturing of polyethylene glycol (PEG) derivatives and advanced polymer materials. The company supplies high-quality PEG products used in pharmaceuticals, biotechnology, drug delivery, and medical devices. Serving global pharmaceutical and research organizations, JenKem Technology supports applications such as PEGylation, which improves drug stability and effectiveness.
3.Merck KGaA
Headquarters: Darmstadt, Germany
Merck KGaA is a global science and technology company specializing in healthcare, life science tools, and electronics materials. Founded in 1668, it is one of the world’s oldest pharmaceutical and chemical companies. Merck KGaA develops prescription medicines, laboratory research products, and specialty chemicals used in biotechnology and semiconductor manufacturing. The company operates through three main sectors: Healthcare, Life Science, and Electronics. Its products support drug discovery, medical treatments, and advanced technologies.
4.Nektar Therapeutics
Headquarters: California, United States
Nektar Therapeutics is a biopharmaceutical company focused on developing innovative medicines for cancer, autoimmune diseases, and chronic inflammatory conditions. The company specializes in polymer conjugate technology and advanced drug delivery systems that improve the effectiveness and safety of therapies. Nektar Therapeutics works on research, development, and clinical trials for novel biologic medicines, often collaborating with major pharmaceutical companies. Its research aims to create treatments that enhance the immune system and improve patient outcomes.
5.SINOPEG
Headquarters: Fujian, China
SINOPEG is a biotechnology and chemical company specializing in the research, development, and manufacturing of polyethylene glycol (PEG) derivatives and advanced polymer materials. Founded in China, the company supplies high-purity PEG products used in pharmaceuticals, biotechnology, medical devices, and drug delivery systems. SINOPEG supports biopharmaceutical companies and research institutions by providing PEGylation reagents that help improve drug stability, solubility, and therapeutic effectiveness.
Are you ready to discover more about the activated polyethylene glycol market?
The report provides an in-depth analysis of the leading companies operating in the global activated polyethylene glycol market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
1. NOF Corporation
1. Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
2. JenKem Technology
3. Merck KGaA
4. Nektar Therapeutics
5. SINOPEG
6. Thermo Fisher Scientific
7. Dr Reddy’s Laboratories
8. Laysan Bio
9. Creative PEGWorks
10. SunBio
11. Other
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the activated polyethylene glycol market.
Conclusion
The global activated polyethylene glycol market is driven by increasing demand for advanced drug delivery systems, rising prevalence of chronic diseases, and expanding applications of PEGylation in biologics and medical technologies. Technological advancements such as multi-arm PEG structures, targeted drug delivery systems, and bio-based PEG production are further accelerating market development. Regionally, North America remains the largest market due to its advanced healthcare infrastructure and strong pharmaceutical presence, while Asia Pacific is emerging as the fastest-growing region due to expanding biotechnology industries and increasing healthcare investments.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?